MedTrace Logo

Preclinical Research for Personalized TCR-T Therapy for Head and Neck Cancer

NCT05697926 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-01-26

No results posted yet for this study

Summary

This study will obtain tumor samples from patients with head and neck cancers and aims to develop personalized TCR-T therapy for head and neck cancer by determining the reactive TCR clone sequences in head and neck cancer.

Conditions

Interventions

OTHER

No intervention

This is a preclinical study. No intervention will be performed.

Sponsors & Collaborators

  • Eye & ENT Hospital of Fudan University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2025-12-31
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05697926 on ClinicalTrials.gov